2228 — QuantumPharm Balance Sheet
0.000.00%
- HK$19.04bn
- HK$30.92bn
- CNY174.42m
Annual balance sheet for QuantumPharm, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 3,829 | 3,468 | 2,825 |
Net Total Accounts Receivable | |||
Net Total Receivables | 47 | 60.9 | 58.3 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 3,920 | 3,597 | 2,945 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 287 | 410 | 584 |
Net Intangible Assets | |||
Long Term Investments | |||
Total Assets | 4,382 | 4,316 | 4,006 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 161 | 198 | 297 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 7,991 | 9,644 | 11,273 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Treasury Stock | |||
Other Equity | |||
Total Equity | -3,609 | -5,328 | -7,267 |
Total Liabilities & Shareholders' Equity | 4,382 | 4,316 | 4,006 |
Total Common Shares Outstanding |